Feature Channels:

Immunology

Add to Favorites Subscribe Share
  • Embargo expired:
    16-Jan-2020 2:00 PM EST

Mosquitoes Engineered to Repel Dengue Virus

University of California San Diego

An international team of scientists has synthetically engineered mosquitoes that halt the transmission of the dengue virus. The development marks the first engineered approach in mosquitoes that targets the four known types of dengue, improving upon previous designs that addressed single strains.

Channels: Children's Health, Engineering, Immunology, Zika Virus, Southeast Asia News, PLOS ONE, All Journal News,

Released:
13-Jan-2020 2:55 PM EST
Newswise: John Theurer Cancer Center Participating in Early-Phase Study of Immunotherapy-Boosting Treatment

John Theurer Cancer Center Participating in Early-Phase Study of Immunotherapy-Boosting Treatment

Hackensack Meridian Health

Investigators at John Theurer Cancer Center at Hackensack University Medical Center in New Jersey are participating in a first-in-patients clinical trial assessing VE800, a novel bacteria-containing therapy, in combination with the immunotherapy drug nivolumab. Laboratory research has suggested that VE800 may enhance the effectiveness of drugs like nivolumab.

Channels: Cancer, Digestive Disorders, Immunology, Liver Disease, Microbiome, OBGYN,

Released:
16-Jan-2020 1:55 PM EST
Research Results
  • Embargo expired:
    15-Jan-2020 5:00 PM EST

Global Team Enables Child With a Fatal Genetic Disease to Recover

Mount Sinai Health System

A young boy with a rare genetic disease that typically kills within weeks of birth is now 3 years old and in remission thanks to a collaborative effort that included physicians at King Saud University Department of Pediatrics and immunologists at the Icahn School of Medicine at Mount Sinai.

Channels: Genetics, Healthcare, Immunology, Pharmaceuticals, NEJM, All Journal News,

Released:
13-Jan-2020 5:50 PM EST
Expert Pitch
and-logo.jpg
  • Embargo expired:
    15-Jan-2020 1:00 PM EST
Released:
14-Jan-2020 11:55 AM EST
Research Results
Newswise: Multimodal Genomic Analyses Predict Response to Immunotherapy in Lung Cancer Patients

Multimodal Genomic Analyses Predict Response to Immunotherapy in Lung Cancer Patients

Johns Hopkins Medicine

Researchers at Johns Hopkins Kimmel Cancer Center, the Bloomberg~Kimmel Institute for Cancer Immunotherapy and the Johns Hopkins University School of Medicine have developed an integrated genomic approach that potentially could help physicians predict which patients with nonsmall cell lung cancer will respond to therapy with immune checkpoint inhibitors.

Channels: Cancer, Healthcare, Immunology, Respiratory Diseases and Disorders, National Institutes of Health (NIH), Nature (journal), All Journal News,

Released:
15-Jan-2020 8:00 AM EST
Research Results
Newswise: NUS researchers discover breakthrough in cancer diagnosis using big data analytics

NUS researchers discover breakthrough in cancer diagnosis using big data analytics

National University of Singapore

A team of researchers from the National University of Singapore has developed a personalised assessment tool which can detect the incidence of cancer, predict patient survivability and determine patient suitability for immunotherapy cancer treatment.

Channels: All Journal News, Cancer, Cell Biology, Immunology, Respiratory Diseases and Disorders, Nature (journal),

Released:
14-Jan-2020 3:50 AM EST
Research Results
Newswise: Douglas Hanahan Appointed Distinguished Scholar of the Ludwig Institute for Cancer Research

Douglas Hanahan Appointed Distinguished Scholar of the Ludwig Institute for Cancer Research

Ludwig Cancer Research

Ludwig Cancer Research is pleased to announce the appointment of Douglas Hanahan as a Distinguished Scholar at the Lausanne Branch of the Ludwig Institute for Cancer Research.

Channels: Cancer, Immunology, In the Workplace,

Released:
14-Jan-2020 3:00 AM EST
Research Results
sum-logo.gif

'Ageotypes' provide window into how individuals age, Stanford study reports

Stanford University School of Medicine

What's your type? That question could gain new meaning, thanks to scientists who've categorized how humans age into different classes dubbed "ageotypes," reports a new study from the Stanford University School of Medicine.

Channels: Aging, Autoimmune Diseases, Cell Biology, Genetics, Immunology, Kidney Disease, Liver Disease, Nature (journal), All Journal News,

Released:
13-Jan-2020 12:50 PM EST
Announcement
Newswise: Taking One for the Team: How Bacteria Self-Destruct to Fight Viral Infections
  • Embargo expired:
    10-Jan-2020 11:00 AM EST

Taking One for the Team: How Bacteria Self-Destruct to Fight Viral Infections

University of California San Diego Health

UC San Diego School of Medicine researchers have discovered how a new immune system works to protect bacteria from phages, viruses that infect bacteria — new information that could be leveraged to improve treatment of multidrug-resistant bacterial infections by refining phage therapy.

Channels: Drug Resistance, Immunology, Infectious Diseases, Pharmaceuticals, National Institutes of Health (NIH), All Journal News,

Released:
8-Jan-2020 4:05 PM EST
Research Results


11.35407